INTRODUCTION
Cyclosporin (CY A),' an oligopeptide fungal metabolite, has potent immunosuppressive effects on T cellmediated immune responses without any remarkable myelotoxicity (1) . Administration of CY A markedly prolonged the survival of major histocompatibility complex (MHC) incompatible organ allografts and in some models, grafts were retained by the host even after the administration of CY A was discontinued (2) . In vitro, CY A suppressed both T cell-proliferative responses (3) and the induction of cytotoxic cells in the mixed leukocyte reaction (MLR) (4) . In our recent studies of the effect of CY A on the MLR in the guinea pig, we have found that in addition to the inhibition of T cell proliferation, CY A led to the induction of a radiosensitive T cell population capable of suppressing the MLR (5) . We report here that these CY Ainduced T cells, after overnight culture with stimulator cells, but in the absence of CY A, secrete a factor (MLR-SF) with marked suppressive activity in the MLR. As this MLR-SF is restricted in its action by the MHC type of the responding T cell in the MLR, our results demonstrate a finely regulated pathway by which CY A may suppress T cell alloreactivity in vivo.
METHODS
Alloreactive responder T cells were generated from inbred nonimmune strain 13 or strain 2 mesenteric lymph node (MLN) cells cultured (5 X 106) with nonimmune, irradiated (2,500 R), unfractionated mineral oil-induced peritoneal exudate cells (PEC) (1 X 106) from strain 2 or strain 13 guinea pigs, respectively, for 7 d in 24 well-vessels (Costar, Data Packaging, Cambridge, MA) in 2 ml of culture medium containing RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) supplemented with L-glutamine (300 ug/ml), penicillin (100 U/ml), streptomycin (100 iig/ml), 5-fluorocytosine (1 ug/ml), 2-mercaptoethanol (5 X l0-5 M), and 5% heat-inactivated normal guinea pig serum. Cultures were treated with CY A, 0.1 ug/ml, or with ethanol alone at a 0.01% final concentration. After this period of culture, the recovered cells were washed three times with a large excess of balanced salt solution containing 5% normal guinea pig serum and recultured in complete medium (4 X 106/ml) together with fresh, irradiated allogeneic strain 2 or 13 PEC (1 X 106/ml) for an additional 20 h. These culture supernatants (designated as MLR-SF) were filtered and kept frozen at -200C until use.
For elimination of T cells, responder alloreactive T cells were divided into two aliquots (6 X 106 cells/ml) of 1 ml each for treatment with antibody and complement. Rabbit complement (Gibco Laboratories), previously absorbed with guinea pig spleen cells (one spleen per 5 ml of rabbit serum) at 00C for 1 h, was used at a 1:5 dilution. Either a control mouse ascites, or the ascites 8BE6, containing an anti-guinea pig T cell-specific monoclonal antibody, were added to give a final dilution of 1:500. Cells were incubated for 45 min at 370C, washed three times, and counted. Control and T cell-depleted lymph node cultures were then each incubated for 20 h in complete medium with irradiated allogeneic PEC as described, and the supernatants were filtered and stored until use.
To test the supernatants for suppressive activity, primary MLR cultures were done as follows. Normal MLN cells from strains 2, 13, (2 X 13)FI, and BIOB (2 X 106/ml) were mixed with either syngeneic or allogeneic irradiated PEC (2 X 106/ ml) in complete culture medium. 100 ul of the cell mixture was added to round-bottom microtiter plates together with either 100 ul of culture medium or 100 til of the MLR-SF preparation to give the indicated final dilutions. Cultures were kept at 37°C, 5% CO2 in a humid environment for a total of 5 d. 18 h before harvesting, 1 MCi of [3H]thymidine (6.7 Ci/mmol, New England Nuclear, Boston, MA) was added to each well. Cells were harvested with the aid of a semiautomated harvesting device (Microbiological Associates, Inc., Walkersville, MD) and incorporated radioactivity was counted by liquid scintillation spectroscopy. The results of. triplicate cultures are presented as the mean counts per minute. The SE was rarely >10% of the mean and was omitted for simplicity. As the supernatants were generated from unfractionated LNC, we next determined the cell type responsible for the production of the MLR-SF. Strain 13 LNC were cultured with strain 2 PEC for 7 d in the presence of CY A, washed, and then treated with a monoclonal antibody specific for guinea pig peripheral T lymphocytes (8BE6, J. Chiba and E. M. Shevach, unpublished observations) in the presence of complement or alternatively a control ascites and complement. The antibody-treated LNC were then cultured for 24 h with strain 2 PEC in the absence of CY A. Responder LNC that had been depleted of T cells by treatment with the monoclonal anti-T cell reagent and complement were unable to produce the MLR-SF, thus indicating that T cells were required for its production (Table II) .
Our initial experiments with the CY A-induced strain 13 anti-2 MLR-SF demonstrated no effect on the strain 2 anti-13 MLR, thus raising the possibility that the MLR-SF had specificity for the I-region phenotype of the responder T cell population in the MLR, as the MHC of strain 2 and 13 guinea pigs differs only in the I-region. To further localize the cellular element serving as target for the MLR-SF induced by CY A, we made use of a third party strain, the partially inbred BIOB strain. The MHC of BIOB guinea pigs differs in its entire I-region from that of both strain 2 and 13 (6) have not yet performed the appropriate backcross analyses to map the action of MLR-SF to the I-region of the guinea pig MHC, the studies with inbred strain 2 and 13 animals whose MHC differ only in the I-region are highly suggestive that the responder T cell population must share the (12, 13) , an alternative use for this drug suggested by our data would be the generation of suppressor T cells in vitro. The recent advances (14) in the growth and maintenance of T cell lines as well as the production of antigen-specific T cell hybridomas should allow for the expansion of such CY A-induced T suppressor populations and facilitate the isolation of large quantities of cell-free supernatants which might be capable of inducing and maintaining specific transplantation tolerance in vivo.
